Key strengths for RGA include steady revenue growth, strong and improving cash generation, and a solid, expanding asset base supported by rising retained earnings. The company has a focused franchise in life and health reinsurance, deep technical and data capabilities, and a history of recognized product innovation that underpins durable client relationships. Its balance sheet leverage appears moderate for the sector, and the surge in free cash flow provides meaningful financial flexibility for dividends, debt service, and selective growth investments.

Main risks center on earnings and margin volatility inherent in the reinsurance business, amplified by sensitivity to claims experience, longevity trends, and investment markets. The upward drift in leverage, unusual reporting of current assets and liabilities, and swings in cash‑flow components all warrant ongoing scrutiny. Strategically, RGA faces intense competition from other global reinsurers and alternative capital, along with potential disruption from new technologies and evolving regulation and accounting standards that may affect capital requirements and reported results.

Based on information through 2024, the outlook appears cautiously constructive: the franchise is growing, cash flows are robust, and the competitive position in life and health reinsurance remains strong. The key questions for the future are whether RGA can maintain underwriting discipline and capital strength through different parts of the cycle, continue to turn innovation into tangible competitive advantage, and manage leverage and portfolio risk prudently. Data anomalies in the most recent reporting period and the natural volatility of the business argue for a measured interpretation of any single year, but the multi‑year trajectory suggests a resilient platform with meaningful opportunities and typical industry‑specific risks.